Death and Dependence: Current Controversies over the Selective Serotonin Reuptake Inhibitors
Open Access
- 1 December 2003
- journal article
- research article
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 17 (4) , 355-364
- https://doi.org/10.1177/0269881103174019
Abstract
Recent years have seen a considerable media interest in the adverse effects of the selective serotonin reuptake inhibitors (SSRIs). This has led to claims that these antidepressants may lead to suicide and homicide and that they cause dependence or even addiction. Such claims have caused great concerns to many patients and have confused doctors in both primary care and psychiatric practice. In this article I review the basis of these claims and show that many seem to emerge from the misinterpretation of evidence and the use of imprecise definitions. Although the SSRIs are not free of problems they compare very favourably with other antidepressants and other classes of psychotropic drugs. There is no evidence they are addictive in the formal sense of leading to a drug dependence syndrome. Some suggestions on the way these issues can be more precisely defined and studied in future are given.Keywords
This publication has 66 references indexed in Scilit:
- Discontinuation Syndrome in Dysthymic Patients Treated with Selective Serotonin Reuptake InhibitorsCNS Drugs, 2002
- Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelinesJournal of Psychopharmacology, 2000
- SSRI discontinuation syndrome treated with fluoxetineInternational Journal of Geriatric Psychiatry, 1998
- Suicide in the 18 Years After Deliberate Self-harmThe British Journal of Psychiatry, 1996
- Serotonin Reuptake Inhibitor WithdrawalJournal of Clinical Psychopharmacology, 1996
- Effects of single and repeated oral administration of fluvoxamine on extracellular serotonin in the median raphe nucleus and dorsal hippocampus of the ratNeuropharmacology, 1995
- Current advances and trends in the treatment of depressionTrends in Pharmacological Sciences, 1994
- Withdrawal Reaction after Long-Term Therapeutic Use of BenzodiazepinesNew England Journal of Medicine, 1986
- ABSTINENCE SYMPTOMS AFTER WITHDRAWAL OF TRANQUILLISING DRUGS: IS THERE A COMMON NEUROCHEMICAL MECHANISM?The Lancet, 1982
- TOFRANIL‐TREATMENT OF ENDOGENOUS DEPRESSIONSActa Psychiatrica Scandinavica, 1959